The safety of incretin-based therapies The widespread extrapancreatic expression of GLP-1 and GIPR raises questions surrounding the long-term consequences of incretin-based therapies for type 2 diabetes and obesity
A team from Harvard University started looking into the possible link after three people taking semaglutide the active ingredient in Ozempic and Wegovy were diagnosed with non-arteritic anterior ischemic optic neuropathy (NAION) within a week
Common side effects The most common side effects of Zepbound include nausea, diarrhea, vomiting, constipation, stomach (abdominal) pain, indigestion, injection site reactions, feeling tired, allergic reactions, belching, hair loss, and heartburn
T Med Spa to see whether Semaglutide can be great for you
How to save money on Zepbound and Ozempic Though Zepbound and Ozempic are expensive weight loss medicines